	A multicenter study of automatic segmentation-based multimodal fusion integrating radiomics, deep learning, and clinical parameters for prostate cancer detection. Abdom Radiol (NY) Ding N, Jin L, Yin S, Ji Y, Wang X, Li M. PMID: 42101624 [PubMed - as supplied by publisher]
	The Impact of Specialist Palliative Care on the Utilization of Health Care Services at the End of Life Among Patients With Prostate Cancer: A Nationwide Register-based Study. Eur Urol Open Sci Carpén TP, Nåhls NA, Nuutinen MSJ, Saarto TH. PMID: 42100443 [PubMed]
	Abdominal disseminated lesions following surgery for a testicular mucinous cystic neoplasm initially diagnosed as mucinous cystadenoma: a case report and literature review. Front Oncol Yang J, Li W, Wang J, Li J. PMID: 42100427 [PubMed]
	Aerobic glycolysis in bladder cancer: research advances and targeted therapy potential. Front Oncol Pan M, Tao T, Kong D, Gong H. PMID: 42100416 [PubMed]
	Mechanistic insights and molecular therapy for neuroendocrine prostate cancer. Front Oncol Niu Y, Zhang S, Zhang S, Tao J, Zhu Y. PMID: 42100391 [PubMed]
	Translational insights into miR-126 and miR-423: biomarkers and therapeutic targets in cancer, cardiovascular, metabolic and kidney diseases. Front Mol Biosci Rodzo. PMID: 42100367 [PubMed]
	Solitary fibrous tumor: A contender in the differential diagnosis of a renal mass. Indian J Urol Kareem Z. PMID: 42099838 [PubMed]
	Machine learning-based integration of systemic immune-inflammation and nutritional signatures for predicting disease-free survival in upper tract urothelial carcinoma: a multicenter study. Front Immunol Peng X, Xiao B, Yuan Z, Xv Y, Xiao M, Shi W. PMID: 42099622 [PubMed - indexed for MEDLINE]
	Gut microbiota and its metabolites: Key factors of drug resistance in the treatment of advanced prostate cancer (Review). Mol Med Rep Song J, Cui H, Yang P, Xu Y, Liu Y, Zhang G, Liu Y, Tian A, Che J, Sun H, Zhang Z. PMID: 42099232 [PubMed - indexed for MEDLINE]
	FOXA1 is a highly sensitive diagnostic marker for prostate cancer including small cell carcinoma of the prostate. Histopathology Zhao J, Yao J, Hosseini H, Baraban E, Lin R, Guo CC, Huo L, Lu W, Khan K, Wang S, Soto LMS, Ding Q. PMID: 42098986 [PubMed - as supplied by publisher]
	Prostate cancer therapeutic strategies decided based on in-bore MRI-targeted prostate biopsies alone, or in combination with TRUS-guided biopsies. World J Urol Schull A, Gachet J, Tavolaro S, Santy A, Bornet G. PMID: 42098380 [PubMed - indexed for MEDLINE]
	Nivolumab plus ipilimumab for chemotherapy-refractory metastatic castration-resistant prostate cancer: results from the randomized portion of the phase 2 CheckMate 650 trial. Nat Commun Sharma P, Krainer M, Saad F, Castellano D, Bedke J, Kwiatkowski M, Patnaik A, Procopio G, Wiechno P, Kochuparambil S, Thomas C, Arranz Arija JÁ, McCune SL, Hansen S, Daugaard G, Delgado Mingorance JI, Kukard C, Subudhi SK, Basu S, Jindal S, Siddiqui BA, Lako A, Gupta S, Fedorov V, Amin NP, Campos A, Wang Y, David JM, Pachynski RK. PMID: 42098105 [PubMed - as supplied by publisher]
	Druggable Genome-Wide Mendelian Randomization Identifies Therapeutic Targets and DNA Methylation-Mediated Regulation in Urological Malignancies. Technol Cancer Res Treat Li T, Wei Q. PMID: 42098041 [PubMed - indexed for MEDLINE]
	Dose dE-eScalaTion IN prostATe radIOtherapy usiNg an MR-Linac in 2 Fractions (DESTINATION 2): protocol for a randomised, phase II/R-IDEAL2b trial. BMJ Open Cooper S, Alexander S, Breitkreutz D, Casey F, Christodouleas J, Dassen MG, Dell'acqua V, Dunlop A, Herbert T, Kolias P, Mitchell A, Pos FJ, Westley R, Tree AC, Van Der Heide UA, Vesprini D. PMID: 42097645 [PubMed - indexed for MEDLINE]
	Outdoor air pollution and prostate cancer risk in the NIH-AARP diet and health study. J Natl Cancer Inst Post LM, Hurwitz L, Fisher JA, Kaufman JD, Koutros S, Jones RR. PMID: 42097289 [PubMed - as supplied by publisher]
	Optimizing Care for Patients With Metastatic Castration-Resistant Prostate Cancer. Am Soc Clin Oncol Educ Book Cren PY, Buteau J, Fatema U, Patel R, Saraiya B, Emmett L, Fizazi K. PMID: 42096668 [PubMed - indexed for MEDLINE]
	Multicenter, Randomized, Phase II Trial of Olaparib Plus Radium-223 Versus Radium-223 in Men With Castration-Resistant Prostate Cancer With Bone Metastases (COMRADE). J Clin Oncol McKay RR, Xie W, Ajmera A, Araneta A, Jamieson C, Folefac E, Hussain A, Kyriakopoulos CE, Manning DK, Olson A, Parikh M, Parikh R, Saraiya B, Pasquina LW, Madison R, Clifford S, Childress M, Gasco A, Ivy P, Van Allen E, Kochupurakkal B, Shapiro GI. PMID: 42096662 [PubMed - as supplied by publisher]
	Autoencoder/RandomForest-TabPFN for Cross-Cancer Metabolomics: Prostate and Breast Cancer Diagnosis Using Paper Spray and Ion Mobility-Mass Spectrometry Techniques. Gigascience Hauns S, Pinto FG, Khyriem C, Singh A, Al-Sadi A, Yazeedi TA, Mohammad R, Cisse B, Garrett TJ, Uddin M, Soares NC, Backofen R, Alkhnbashi OS. PMID: 42096511 [PubMed - as supplied by publisher]
	[Solitary fibrous tumor of the prostate mimicking a tumor of the vesicoprostatic junction. Case report]. Rev Med Inst Mex Seguro Soc Díaz-Fuentes H, Zapot-Martínez JC, Cabrera-Mora NA, Ramos-Arceo E, Tavares-García JS. PMID: 42096255 [PubMed - indexed for MEDLINE]
	[First cohort: Robotic radical prostatectomy at the Mexican Institute for Social Security]. Rev Med Inst Mex Seguro Soc Fuziwara-Ruíz S, Hernández-Toriz N, Huerta-Gómez JC, Quintero-Becerra J, Martínez-Cornelio A, Zapot-Martínez JC, Delgado-Herrera A, Castro-Chávez C, Pérez-Ramírez O. PMID: 42095811 [PubMed - indexed for MEDLINE]

Articles 1 - 20 / 178073

Page 1 of 8904



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy